To compare outcomes at a 5-year median follow-up among different partial nephrectomy (PN) approaches: robot-assisted (RAPN), laparoscopic (LPN) and open partial nephrectomy (OPN).
Introduction
Partial nephrectomy (PN) has become the standard surgical treatment for T1a renal tumours (<4 cm), and for T1b tumours whenever feasible [1] . This technique has the advantage of preserving renal function, thus delaying progression to chronic renal insufficiency, compared with radical nephrectomy (RN) [2] . Laparoscopic PN (LPN) was introduced as an alternative option to open PN (OPN) for the surgical treatment of small renal masses in 1993. Despite the attractiveness of minimally invasive techniques, there were limitations, including technical difficulties of tumour dissection and intracorporeal suturing [3] ; however, with the introduction of robotic technology in urology, its application in renal surgery has been increased. Patel et al. [4] reported that the use of PN surgery for treatment of renal masses is on the rise, and this increase is associated with the introduction of robotic technology [4] . Robotic technology has overcome the difficulties in LPN surgery, allowing meticulous dissection of the tumours and renorrhaphy completion within a shorter time, and has led to improved peri-operative outcomes compared with OPN and LPN. Recent systematic reviews and meta-analyses have shown that RAPN has the advantages of shorter length of hospital stay (LOS), less estimated blood loss (EBL) and shorter warm ischaemia time (WIT) [5, 6] .
While the literature is filled with comparative studies between two PN approaches [7, 8] , only few studies have compared the peri-operative and short-term outcomes of the three PN approaches RAPN, LPN and OPN [9] [10] [11] . Moreover, long-term comparison of the three approaches is lacking.
To the best of our knowledge, this is the first multicentre study comparing the long-term oncological and functional outcomes of propensity-matched cohorts of patients undergoing RAPN, LPN or OPN at a median of 5 years' follow-up.
Materials and Methods

Study Population
In our prospectively collected, approved renal surgery database (institutional review board no. 2014-009-001), we identified 1 308 PN cases (RAPN, n = 380; LPN, n = 206; OPN, n = 722) performed by six surgeons between 2006 and 2012, who were skilled in performing RAPN, LPN or OPN, at four academic centres in South Korea. The four centres performed 885, 258, 85 and 80 PNs, respectively. The majority of RAPN surgeries (n = 307) were performed at one centre (Yonsei Severance Hospital). All surgeons had experience of >50 cases of RAPN, LPN and/or OPN. Patients with localized renal tumours who had a healthy contralateral kidney and complete medical records were included. We performed 1:1:1 propensity-score-matching adjustment based on confounding variables among groups ( Renal function assessment was based on serum eGFR measurements at regular intervals of 1, 3, 6, 12 months, and then yearly. eGFR was calculated using the Modification of Diet in Renal Disease formula. CKD stage was based on the National Kidney Foundation Kidney Disease Outcome Quality Initiative (NKF-KDOQI) Classification. CKD upstaging was considered as a change of one class of CKD or more.
Oncological outcomes were evaluated through routine postoperative follow-up imaging studies, e.g. chest X-ray, CT of the chest, abdominal CT and/or MRI. Imaging was carried out at 6, 12 months, then yearly and when clinically indicated. Events of local recurrence, distant metastasis, death from cancer, and all causes of death were reviewed and analysed. Local recurrence was defined as detection of a new enhancing lesion, specifically in the surgical bed or in the same region (e.g. lower pole or renal fossa). Distant metastasis was defined as disease recurrence in the contralateral kidney or other body organs. Events of death from RCC and events of death from any other cause were collected from the medical records of the hospitals.
Surgical Technique
The following factors determined the surgical approach (RAPN or LPN or OPN): surgeon's preference; patients' preference; and the introduction of robotic surgery. We used the previously described protocol and trocar arrangement for LPN and RAPN [12, 13] . We used a three-arm or four-arm approach depending on the surgeon's preference. The open technique was performed with the patient in a full-flank position via an anterior subcostal incision below the 11th rib. The renal artery was clamped using a bulldog clamp or with a clampless procedure at the surgeon's discretion. The parenchymal defect and/or opened calyces were repaired.
Outcome Measurements
The primary endpoint was comparison of the long-term oncological and functional outcomes among RAPN, LPN and OPN. 
Statistical Analysis
Propensity score matching was carried out using logistic regression modelling for each patient based on presumed covariates, including age, CCI, tumour size, RENAL nephrometry score, and preoperative eGFR. Patients were then matched without replacement at a 1:1:1 ratio on those scores. To match these three treatment methods, 1 vs 2 was first matched, and the results of matched 1 vs 2 were then matched with 3. Then, the propensity score was used; matching was performed starting from the eighth digit of the decimal point to the first digit of the decimal point. An unmatched case at the first decimal place became an unmatched patient. Demographic, peri-operative, renal functional and oncological outcomes were evaluated through ANOVA, a linear mixed model (for continuous variables), generalized estimating equations (for categorical variables), the chi-squared test and pairwise comparison tests (paired t-test for continuous variables and McNemar's test for categorical variables). Kaplan-Meier survival curves were used to compare the local recurrence free-survival, metastasis-free survival, cancer-specific survival and CKD-free survival rates among the three groups. P values of <0.05 were taken to indicate statistical significance. All statistical analyses were performed using SAS (version 9.4; SAS Inc., Cary, NC, USA).
Results
We included 1 308 patients who underwent PN (RAPN, n = 380; LPN, n = 206; OPN, n = 722) at four academic centres. Before propensity score matching, there were significant differences among the three groups in age, CCI, tumour size, preoperative eGFR and RENAL nephrometry score (P = 0.004, 0.009, 0.018, 0.01, and 0.002, respectively; Table 1 ). Thus, we performed propensity-score-matching adjustment for these confounding variables. The final sample size was 122 cases for each group. After matching, the analysis revealed no significant differences among the three groups regarding age (P = 0.923), CCI (P = 0.880), tumour size (P = 0.384), preoperative eGFR (P = 0.556) or RENAL score (P = 0.650; Table 1 ). The median (interquartile range) follow-up periods were 60 (48-73) months, 60 (46-70) months and 64 (52-77) months for RAPN, LPN and OPN, respectively (P = 0.331).
Peri-operative and renal function outcomes are summarized in Table 2 . In the matched groups, RAPN was associated with significantly lower mean EBL compared with LPN (167.7 vs 196.1 mL, P = 0.025) and OPN (167.7 vs 206.4 mL; P = 0.040), while LPN had a longer mean OT compared with RAPN (241.9 vs 182.5 min; P = 0.001) and OPN (241.9 vs 172.5 min; P = 0.001). The mean LOS was shorter in the RAPN group compared with the OPN (P = 0.045) and the LPN (P = 0.042) groups. The mean WIT was 22 min vs 27.1 min in the RAPN and OPN groups, respectively (P = 0.018). Intra-operative complication rates were higher in the LPN group (7.4%) compared with the RAPN and OPN groups (4.9% and 3.3%, respectively). The incidence of Clavien-Dindo grade ≥ 3 complications was 5.7%, 7.3% and 7.3% in the RAPN, LPN and OPN groups, respectively (P = 0.842). Twenty-five patients had major complications, including seven urine leakages, which were treated successfully by insertion of a ureteric stent, 13 angioembolizations for postoperative bleeding and five reoperations for postoperative bleeding. The overall trifecta achievement rate in patients with cT1 disease was 61.4% in RAPN, 50.8% in LPN, and 64.7% in OPN. Regarding renal function outcomes, the median eGFR value was lower in LPN (74 mL/min/1.73 m 2 ) compared with OPN (84 mL/min/1.73 m 2 ; P = 0.045) at the latest follow-up. The distribution of postoperative CKD stages at last follow-up was similar in the three groups (P = 0.484). The incidence of CKD upstaging was significantly lower in RAPN (20.5%) compared with LPN (32%, P = 0.035) and OPN (33%, P = 0.038). The 5-year CKD-free survival was significantly higher (78.4%) in the RAPN group compared with the LPN and OPN groups (58.8% and 65.8%, respectively; log-rank P = 0.031) (see Fig. 1d ).
Oncological outcomes are summarized in Table 3 . In the matched groups, there were no significant differences in the distribution of benign tumours (P = 0.832), Fuhrman grades (P = 0.217) or histological subtypes (P = 0.438) among the three groups; however, the incidence of pT1b and ≥pT2 stages was higher in the RAPN compared with the OPN group (P = 0.010) and LPN (P = 0.041). The incidence of PSMs was three (2.5%), five (4.1%) and two (1.6%) in the RAPN, LPN and OPN groups, respectively (P = 0.358). Eight patients with PSMs had pT1a RCC and two patients with PSMs had pT1b RCC. Only one patient among them had adrenal metastasis 17 months after surgery, and this patient remains alive. Nine deaths (two [1.6%], one [0.9%] and six [4.9%] in each group; P = 0.779) occurred in this cohort during the follow-up period. Among them, four deaths were not related to RCC, whereas five deaths were related to RCC. Four patients had multiple metastasis 8, 10, 12 and 24 months after surgery and died 12, 13, 18 and 46 months after surgery, respectively, and one patient had adrenal metastasis 7 months after surgery and died 60 months after surgery. The 5-year cancer-specific survival rate was 90.2%, 86.9% and 88.5% (log-rank, P = 0.922) and the metastasisfree survival rate was 98.4%, 99.2% and 98.4% (log-rank, P = 0.798) in the RAPN, LPN and OPN groups, respectively (Fig. 1) .
Discussion
Partial nephrectomy has the advantages of preserving renal function and providing long-term functional benefits. Several studies have shown that the curative potential of PN is equal to that of RN in the treatment of localized RCC. These studies found equivalent oncological outcomes between PN and RN, while PN can provide superior renal functional outcomes to those of RN [14] . RAPN has several advantages, such as accurate tumour dissection, easy intracorporeal suturing, and better peri-operative outcomes compared with OPN and LPN [14] ; however, the high cost of RAPN may still be a barrier to more dissemination and application in PN surgery. In a large US population-based study, Yu et al. [15] compared the use, costs and outcomes of robot-assisted laparoscopic surgery vs laparoscopic surgery and open surgery, and found that robot-assisted and laparoscopic surgery were associated with fewer deaths, complications, transfusions and shorter LOS compared with open surgery, but robot-assisted laparoscopic surgery was more costly than laparoscopic and open surgery.
In the present study, we present a multicentre propensityscore-matched comparative analysis among RAPN, LPN and OPN with regard to their peri-operative, long-term functional and oncological outcomes. To the best of our knowledge, this is the first study in the literature to provide a long-term comparative analysis of the three surgical approaches.
In the present study, patients in the RAPN group had lower EBL and shorter LOS compared with patients in the LPN and ¶ Patients were evaluated at last follow-up period of median 60, 60 and 64 months in RAPN, LPN and OPN, respectively. **CKD upstaging was defined as a change in one class of CKD or more. Bold indicates significant value (P < 0.05).
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© 2018 The Authors BJU International © 2018 BJU International OPN groups, while the OT was longer in the LPN group compared with the RAPN and OPN groups. Previous systematic reviews and meta-analyses have emphasized the advantages of the minimally invasive RAPN compared with LPN [5] and OPN [6] , such as a shorter LOS and less blood loss. Recently, Lucas et al. [9] compared 96 patients who underwent PN (27 RAPN, 15 LPN and 54 OPN) and found that LPN had a longer mean OT (195 min; P < 0.001) compared with RAPN (190 min) and OPN (147 min). In another recent study, Luciani et al. [10] evaluated the perioperative outcomes of 253 PN cases (110 RAPN, 70 LPN and 73 OPN) in a prospective cohort study. They found a significantly shorter LOS in the RAPN group compared with the LPN (P < 0.001) and OPN (P = 0.003) groups (Table 4) . Notably, WIT was shorter in the RAPN group compared with the OPN group and the intra-operative complications were more common in the LPN group. Choi et al. [5] reported that RAPN was associated with a lower conversion rate to RN and a shorter WIT compared with LPN.
In the present study, the overall trifecta achievement rate for cT1 disease in the three groups was 59%, and was lower in the LPN (50.8%) than in the RAPN (61.5%) and OPN (64.8%) groups. This trifecta provides us with important data about the surgical quality and efficiency; however, its impact on the long-term outcomes of PN is still unknown. Many studies have reported varying trifecta achievement rates (31-79%) in RAPN, LPN and OPN [16, 17] . Acar et al. [18] compared the trifecta outcomes of RAPN and OPN, and reported rates of 77% and 76%, respectively, with no difference between the two techniques. Minervini et al. [17] reported trifecta rates for cT1a of 78.6% and 74.3% in OPN and LPN, respectively. They found that the surgical approach was not a significant predictor of a negative trifecta in multivariable analysis. Recently, the trifecta for clinical T1b renal tumours in a multicentre prospective dataset was achieved in 62.4%, 63.2% and 69.5% of OPN, LPN and RAPN cases, respectively (Table 4) [11] .
Regarding the oncological outcomes, the PSM rates in the present study were 2.5%, 4.1% and 1.6% after RAPN, LPN and OPN, respectively (P = 0.358). Similarly, Porpiglia et al. [11] compared the peri-operative outcomes of OPN (n = 133), LPN (n = 57) and RAPN (n = 95) for cT1b renal tumours, and they reported rates of 2.5%, 1.9% and 8.6% after RAPN, LPN and OPN, respectively. There was no significant difference in PSM rate among the three surgical approaches [11] .
To the best of our knowledge, this is the first study to compare the long-term survival rates among RAPN, LPN and OPN. When stratified by surgical approach, the 5-year cancer-specific survival rates were 90.2%, 86.9% and 88.5% and the 5-year metastasis-free survival rates were 98.4%, 99.2% and 98.4% in the RAPN, LPN and OPN groups, respectively. Notably, the cancer-specific survival and metastasis-free survival rates were similar to each other (logrank P > 0.05). The survival rates in the present study are consistent with previous studies on different PN approaches. Andrade et al. [19] reported the overall (91.1%) and cancerspecific survival rates (97.8%) associated with RAPN with a 5-year follow-up, and Herr et al. [20] reported overall (93%) and cancer-specific survival rates (97%) after OPN with a ) groups at the latest follow-up, but the difference was not statistically significant (P = 0.056). In addition, the rate of CKD upstaging was lower in the RAPN group (20.5%) than in the LPN (32.0%) and the OPN groups (33.6%; P = 0.048). In the present study, CKD upstaging was defined as a change in one class of CKD or more. CKD is a general term for heterogeneous disorders affecting the structure and function of the kidney. This concept was developed by the NKF-KDOQI in 2002 and guidelines have recommended a shift from kidney disease being recognized as a life-threatening disorder to a common disorder of varying severity. This shift has resulted in an emphasis on early detection and management [22, 23] . The incidence of CKD upstaging in the present study is consistent with previous reports. Khalifeh et al. [24] reported a 20.2% rate of upstaging of CKD after RAPN with 3 years follow-up. Andrade et al. [20] reported rates of 26.9% and 59.6% for upstaging of CKD after RAPN and LPN, respectively. In addition, Kumar et al. [25] reported CKD upstaging rates ranging from 11.8% to 33.1% after RAPN.
The present study has some limitations. First, it is a retrospective study in which selection bias might be introduced when a patient is selected for one surgical approach over another. A prospective randomized controlled trial would be an ideal choice to overcome this limitation. Second, renal function assessment was determined by serial eGFR measurements, which do not allow assessment of each renal unit as would a renal isotope scan, but the latter is not a routine imaging method in the postoperative follow-up after PN in our centres. Third, the study included different surgeons' and centres' experience, which might potentially have influenced the outcomes (e.g. the majority of RAPN procedures were performed at one centre); therefore, there is potential confounding between 'treatment' and 'study centre' and the results should therefore be interpreted with caution; however, it is clear that the intra-operative, peri-operative and trifecta outcomes were consistent with previous PN results, as discussed above. In addition, multicentre results and different surgeons might represent a source of an external data validation. Lastly, analysing a subset of patients (122 out of 722 OPN patients) for the propensity score comparison might not be a representative of the whole OPN experience; however, supplementary data (Tables S2 and S3) showed similar long-term results when comparing the three surgical approaches before and after propensity score matching. There were some differences in peri-operative variables, such as EBL, WIT, OT and LOS, among the surgical approaches, but these are technique-related and mostly would not have an impact on long-term outcomes. PN, regardless of the surgical approach, is the standard treatment for patients with T1 renal masses, with similar long-term functional and oncological outcomes for the three approaches.
Additional strengths of the present study include the fact that it was a large multicentre study. As it would be difficult to perform a prospective randomized controlled study to compare the three surgical approaches, we performed propensity-score-matching analysis of the three approaches to reduce bias as far as possible and to eliminate the differences among the groups. The study included the largest sample to date in which the three surgical approaches were compared, and is also the first study to compare the long-term functional and oncological outcomes of the three approaches.
In summary, the study showed that RAPN, LPN and OPN led to equivalent oncological control at a median follow-up of 5 years. In terms of functional outcomes, RAPN was associated with a lower incidence of CKD upstaging compared with OPN and LPN. Although challenging, a prospective randomized trial is warranted to verify these results.
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